Induced Remote Ischemic Pre-conditioning on Ischemia Reperfusion Injury in Patients Undergoing Coronary Artery Bypass
|
|
- Primrose Roberta Ford
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Induced Remote Ischemic Pre-conditioning on Ischemia Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Nasir Ali 1, Farwa Rizwi 2, Afsheen Iqbal 1 and Azhar Rashid 1 ABSTRACT Objective: To determine the role of remote ischemic pre-conditioning (ripc) on myocardium, against ischemia reperfusion injury in patients undergoing coronary artery bypass graft (CABG) surgery by measuring CKMB levels. Study Design: A randomized controlled trial. Place and Duration of Study: The Surgical Department of Armed Forces Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi, from January to June Methodology: One hundred patients with double and triple vessels coronary artery disease were randomized in two groups of 50 each. ripc protocol consisted of 3 x 5 minutes of forearm ischemia, induced by a blood pressure cuff inflated to 200 mmhg, with an intervening 5 minutes of reperfusion, during which the cuff was deflated. Patients in the control group were not subjected to limb ischemia. The protocol of induced ischemia was completed before placing patients on extracorporeal bypass circuit. At the end of surgery serum CKMB levels were measured and compared at 8, 16, 24 and 48 hours from both the groups. Written informed consent was taken from patients. Study was approved by the hospital ethical committee. Results: Remote ischemic pre-conditioning significantly reduced CKMB levels at 8, 16, 24 and 48 hours after surgery with p-values of 0.026, 0.021, and respectively. There was mean reduction of 3 iu/l in CKMB levels, in patients who underwent ripc protocol prior to CABG surgery, compared to control group. Conclusion: This study showed a significant reduction of enzyme marker CKMB in patients subjected to ripc prior to CABG surgery. This suggests lesser degree of myocardial damage compared to control group in CABG patients. Key words: Coronary artery bypass grafting (CABG). Creatine kinase myocardial band (CKMB). Ischemic pre-conditioning (IPC). Remote ischemic pre-conditioning (ripc). INTRODUCTION Ischemic heart disease (IHD) is currently the leading cause of morbidity and mortality in the developed world. 1 According to a report by World Health Organization on ischemic heart diseases in 2005, IHD would become the leading cause of death in the world by the year Patients with severe IHD that require coronary artery bypass graft (CABG) surgery, although protected by techniques such as cross-clamp fibrillation and cardioplegia, still sustain significant myocardial injury as evidenced by perioperative troponin T or I or CK-MB release. 2 Novel treatment strategies are required to limit the myocardial injury sustained by patients undergoing 1 Department of Cardiac Surgery, Armed Forces Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi. 2 Department of Community Medicine, Islamabad Medical and Dental College, Islamabad. Correspondence: Dr. Farwa Rizvi, Community Medicine Department, Islamabad Medical and Dental College, Bara Kahu, Islamabad. farwa.rizvi@hotmail.com Received October 08, 2008; accepted April 28, CABG surgery in order to improve the clinical outcome of this patient group. Ischemic pre-conditioning (IPC) is the most powerful innate mechanism to protect against ischemia reperfusion injury. 3 This involves a brief period of sub-lethal local tissue ischemia that confers protection against a subsequent lethal ischemia. A more intriguing form of ischemic pre-conditioning with potentially greater clinical significance is remote ischemic preconditioning ripc i.e. transient tissue ischemia at a distance may confer subsequent protection of an organ subjected to potentially lethal ischemia. 4 Przyklenk in 1993 and later Birnbaum et al. in 1997 demonstrated the phenomenon of remote ischemic preconditioning in animal models, whereby transient limb ischemia could reduce myocardial injury caused by prolonged coronary artery occlusion. 5 This magnitude of protection in remote pre-conditioning certainly approaches to local ischemic pre-conditioning in the context of myocardial protection in animal models. 6,7 It was observed that remote ischemic pre-conditioning modifies expression of at least 30 proinflamatory genes involved in leukocyte activation. This anti-inflammatory response is more global in remote ischemic preconditioning as compared to local ischemic preconditioning. 8 Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (7):
2 Nasir Ali, Farwa Rizwi, Afsheen Iqbal and Azhar Rashid In the heart, ripc incurs protection against ischemia reperfusion injury by K + ATP channel dependent mechanism, similar to local pre-conditioning, 9,10 but the details as to how protection is transferred to distant organs is still largely unknown. This may involve humoral factors and autonomic system. 11 Clinical trials of ripc carried out in children undergoing corrective cardiac surgery for congenital heart diseases have shown promising results. 12 Trials of ripc in adults undergoing cardiac surgery are under way at many centers in the world. The rationale for conducting this study in CABG group only was that, since procedure-associated tissue injury is minimum in CABG patients, release of enzyme CKMB will have a better positive predictive value for ischemia rather than surgery associated myocardial injury. This study was designed to determine the protective effects of ripc in reducing myocardial damage against ischemia reperfusion injury by measuring postoperative CKMB levels. METHODOLOGY Between January and June 2008, 100 patients with double and triple vessel disease, who were candidates for coronary artery bypass surgery were prospectively randomized into 2 groups. Group A (n=50) patients undergoing ripc prior to bypass surgery. Group B (n= 0) or controlled group, undergoing bypass surgery without ripc. Random allocation of patients to either ripc group or controlled group was done by lottery method. Ward Incharge was given 100 sealed non-transparent envelops allocating patient to either of the study group. These sealed envelops were sent to operation theatre along with patient s documents. Envelops were opened by the operating surgeon or anaesthetist incharge, and patients were placed in either of the study group, mentioned in the envelop. The ripc protocol comprised of 3 x 5 minutes of forearm ischemia, induced by a blood pressure cuff inflated to 200 mmhg with an intervening 5 minutes of reperfusion during which the cuff is deflated. The control protocol consisted of placing a deflated cuff on upper arm for 30 minutes. This ischimia protocol was adapted from a similar study by Cheng et al. in children undergoing corrective open heart surgery. 12 The ripc protocol was implemented after the patient was anaesthetized and completed prior to placing the patient on extra corporal bypass circuit. All the procedures were performed by a single surgeon to keep the operator dependant variables such as cross clamp time and bypass time within a predictable limit. All patients undergoing elective CABG surgery were included in the study. The exclusion criteria consisted of significant renal or hepatic disease, which could influence the enzyme kinetics in the blood, haemodynamic instability ECG changes and/or raised cardiac enzymes suggesting ongoing ischemia and infarction, acute MI during last 4 weeks, and significant peripheral vascular disease. Written informed consent were taken from all the patients. Project was approved by the ethical committee of the hospital. Study protocol was approved by CPSP review board. Standard non-pulsatile moderate hypothermic cardiopulmonary bypass with a membrane oxygenator was used. Warm blood hyperkalemic cardioplegia delivered through either antegrade or both antegrade and retrograde route in patients with left main stem (LMS) or equivalent disease was used to ensure myocardial protection. All patients were operated under general anaesthesia. An aneroid cuff was placed either on right or left upper arm. In patients undergoing ripc, the cuff was inflated to 200 mmhg for 5 minutes, followed by a 5 minutes interval in which cuff was deflated to allow reperfusion. Three cycles of induced ischemia followed by reperfusion were carried out. Pedical left internal memory artery (LIMA) and saphenous vein grafts were harvested. Patient was heparinized to achieve the activated clotting time (ACT) between 400 to 600 seconds. Aortic and two stage venous cannulation done and cardiopulmonary bypass established. Systemic temperature was lowered to 34 o C. Heart was arrested by giving cardioplegia after clamping aorta. Target vessels anastomosed with conduits. Aortic clamp released after anastomosing LIMA to left anterior descending artery (LAD). Proximal ends of vein grafts anastomosed to aorta. Patient weaned off from cardiopulmonary bypass. Effects of heparin reversed with a measured dose of protamine before decannulation. CKMB in serum was measured on photometric system, Vitalab Selecta. The reagent used was CKMB-FS. CKMB levels 5 times or more, the upper limit of reference range (> 5 ULR) were taken as suggestive of peri operative myocardial infarction. 13 Statistical analyses were performed using statistical software package SPSS version Independent variable was ripc stimulus. Dependent variables were postoperative. CKMB levels measured at 8, 16, 24 and 48 hours after surgery. Confounding variables were cross clamp time, bypass time and body mass index (BMI). Data is presented as mean + SD. Comparison between treatment groups was made with the unpaired student t test. A value of p < 0.05 was regarded as significant. RESULTS No significant difference was noted in terms of age in either group. Mean age in ripc group was years and years in the control group. Patient s characteristics such as co-morbid conditions, signs and symptoms and medication history is given in Table I. 428 Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (7):
3 Induced remote ischemic pre-conditioning on ischemia reperfusion injury in patients undergoing coronary artery bypass Table I: Patient characteristics. Control (n=50) RIPC (n=50) Age (years) Male/female 42/8 47/3 Diabetes 8 (16%) 11 (22%) Hypercholesterolemia 18 (36%) 21 (42%) Hypertension 22 (44%) 13 (26%) Previous myocardial infarction 8 (16%) 11 (22%) Previous stroke Smoking Current smokers 3 (6%) 02 (4%) Ex-smokers 9 (18%) 07 (14%) Never smoked 38 (76%) 41 (82%) Family history of IHD 04 (8%) 03 (6%) Body-mass index Dyspnoea NYHA class Class I 27 (54%) 24 (48%%) Class II 22 (44%) 22 (44%) Class III 01 (2%) 04 (8%) Angina CCS class Class I 6 (12%) 04 (8%) Class II 31 (62%) 34 (68%) Class III 11 (22%) 12 (24%) Class IV 02 (4%) 00 Ejection fraction > 55% 27 (54%) 23 (46%) 30-55% 19 (38%) 23 (46%) < 30% 04 (8%) 04 (8%) Drug history Aspirin 03 (6%) 05 (10%) β blocker 45 (90%) 43 (86%) ACE-inhibitor/ACE antagonist 22 (44%) 20 (40%) Long-acting nitrates 44 (88%) 42 (84%) Data are given as percentage (%) and SD; CCS=Canadian Cardiovascular Society; IHD= Ischemic heart disease; NYHA=New York Heart Association; RIPC=Remote ischemic pre-conditioning. Pre-operative intra aortic balloon pump (IABP) was placed in 8 individuals, 4 patients of each group. All those individuals with IABP had low left ventricular ejection fraction (LVEF < 30). None of the patients experienced peri-operative myocardial infarction based on the ECG and CKMB levels criteria. There were no major neurological complications in either group. Endarterectomy was carried out in 20 patients, 11 patients from the ripc group and 9 from the control group. Postoperative mild inotropic support was given in 19 patients out of 50 in the ripc group and 22 patients out of 50 in the control group. BMI (body mass index) in patients in ripc group was while in control group BMI was (p=0.363). Number of grafts were slightly more in control group. Mean compared to ripc group (p=0.1552). Bypass time in ripc group was minutes, while in control group it was minutes (p=0.945). Clamp time in ripc group minutes, and in control group was minutes (p=0.883). Postoperative CKMB levels were measured at 8, 16, 24 and 48 hours. Base line CKMB levels in both the groups were similar. Baseline CKMB levels in patient undergoing RIPC protocol were slightly higher than the control group but were statistically insignificant i.e iu/l as opposed to iu/l (p=0.725). Eight hours after surgery CKMB levels were significantly lower in ripc group as compared to control group i.e iu/l in ripc group compared to iu/l in control group with p= Similar trend was noticed at 16, 24 and 48 hours postoperative period. These values are summarized in Table II. Table II: CKMB levels (iu/l) in control and ripc group with p-values at 8, 16, 24 and 48 hours. CKMB n= Mean +SD (iu/l) p-value Control ripc Pre bypass p = hours p = hours p = hours p = hours p = DISCUSSION This study showed that remote ischemic preconditioning mediated by transient limb ischemia can reduce myocardial injury and thus CKMB levels in patients undergoing coronary artery bypass surgery. Cardiopulmonary bypass (CPB) is a highly sophisticated life support system in cardiovascular surgery. The system is used to temporarily perform the functions of the heart (circulation of blood) and lungs (gas exchange) during surgical procedures on the heart and great vessels. In most CPB procedures, a cross clamp is applied to the ascending aorta proximal to the site of aortic cannulation, excluding the coronary arteries from the extracorporeal circuit. This makes it possible to arrest the heart by giving cardioplegia through the aortic root and providing a non-contracting heart and a field without blood in which surgeons can work. However, application of aortic cross clamp itself causes myocardial ischemia. Various types of cardioplegia preparations greatly reduce metabolic O 2 requirement of the heart during X-Clamp application but do not abolish it completely. Reduced oxygen supply to myocardium during ischemic clamp time impairs mitochondrial respiration, depleting cells of ATP with subsequent build-up of anaerobic metabolites, reactive oxygen species and intracellular calcium leading to cell death via necrosis and apoptosis. 14 Although successful reperfusion is mandatory for tissue salvage, re-establishing blood flow institutes a cascade of events similar to an inflammatory response. This involves adhesions of circulatory neutrophils to the vascular wall with subsequent tissue invasion and release of proteases, elastases and reactive oxygen species. While this may be an integral part of healing process, it may also contributes to tissue injury. 15 Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (7):
4 Nasir Ali, Farwa Rizwi, Afsheen Iqbal and Azhar Rashid Endogenous protective mechanisms against a range of tissue insults have been identified in all mammalian species. The best characterized is ischemic preconditioning, whereby sub-lethal ischemia induces a state of protection against subsequent prolonged ischemia. Although this phenomenon was described almost 15 years ago, it is slow to be translated into clinical practice. Several clinical trials have recently reported that remote ischemic pre-conditioning reduces myocardial injury after major cardiovascular surgery. 16 This phenomenon has been extensively investigated in myocardium of many species, where it can reduce infarct size by up to 75%. 17 Mechanisms involved in ischemic pre-conditioning are very complex. They induce an early phase preconditioning, which occurs in minutes after applying sublethal ischemia and late phase pre-conditioning that occurs 24 hours after the pre-conditioning stimulus and lasts up to 72 hours. 18 In early pre-conditioning, number of stimuli, generated during hypoxia such as adenosine, bradykinin, endogenous opiates and reactive oxygen species, activate complex second messenger system that converge on mitochondria of ischemic tissue to activate K + -ATP channels, which is responsible in maintaining cell homeostasis and protecting it from ischemic insult. 19 A late phase of pre-conditioning also termed as second window of protection occurs 24 hours after the pre-conditioning stimulus. This is more prolonged than early phase and lasts up to 72 hours. The prolonged interval (24hours) between preconditioning event and its renewed protection after 24 hours is consistent with new protein synthesis which triggers events inside the target cells, similar to early pre-conditioning. 20 Although local ischemic preconditioning phenomenon has been widely studied in animal models, it has failed to establish as a regular practice in medicine, This is due to the fact that preconditioning stimulus has to be applied directly to the organ which is at risk, which poses obvious logical difficulties, when the organ is the human heart or brain. The protective effects of remote ischemic preconditioning in animal models have been demonstrated. The magnitude of this protection approaches that of local ischemic pre-conditioning in the context of myocardium. Detailed mechanism remains unclear how protection is transferred from one tissue to another. 21 In ripc there is evidence for a role of autonomic nervous system in pre-conditioning distant organs. Studies have shown that this protection can be abolished by ganglionic blockers like hexamethonium, without affecting local pre-conditioning. 22 However, unidentified humoral mediators have also been suggested in other studies since protection is being transferred from on animal to another by administration of a plasma fraction or whole blood. 23 This clinical study was designed to prove or otherwise the concept of remote ischemic pre-conditioning by measuring postoperative CKMB levels in CABG patients. This study was carried on relatively stable patients undergoing CABG surgery to keep the patient and disease associated variables within predictable limits. However, one might expect that in high-risk patients or in procedures with extended cross clamp and bypass time remote ischemic pre-conditioning might confer an even greater reduction in myocardial injury. This study is based on measuring post procedure CKMB levels. CKMB, although very sensitive and most commonly used marker for myocardial damage, is not highly specific. Extensive damage to skeletal muscle may give rise false positive results. Trop T and Trop I quantitative test are more specific to myocardial damage. Quantitative assays of these enzymes are expensive and require special lab facility. Currently such facility is not available at our institution. Similar study with Trop T or Trop I quantitative assays on a larger group of patients may be carried out in future to substantiate our findings. CONCLUSION ripc may have therapeutic potential in clinical practice. This study showed a significant reduction of enzyme marker CKMB, suggesting lesser degree of myocardial damage pre-conditioned patients, compared to control group undergoing CABG. REFERENCES 1. Mendis S, Abegunde D, Yousuf S, Ebrahim S, Shaper G, Ghannem H, et al. WHO study on prevention of myocardial infarction and stroke (WHO-PREMISE). Bull World Health Organ 2005; 83: Zaugg M, Schaub MC, Foex P. Myocardial injury and its prevention in the peri-operative setting. Br J Anaesth 2004; 93: Weman SM, Karhunen PJ, Penttilä A, Järvinen AA, Salminen US. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg 2000; 70: Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol 2005; 46: Birnbaum Y, Hale SL, Kloner RA. Ischemic pre-conditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: Kharbanda RK, Li J, Konstantinov IE, Cheung MM, White PA, Frndova H, et al. Remote ischemic pre-conditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart 2006; 92: Epub 2006 Jul 3. Comment in: p Hausenloy DJ, Mwamure P, Venugopal V, Harris J, Mac Allister RJ, Barnard M, et al. Remote ischemic pre-conditioning using 430 Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (7):
5 Induced remote ischemic pre-conditioning on ischemia reperfusion injury in patients undergoing coronary artery bypass transient arm ischemia reduces myocardial injury during cardiac surgery. Circulation 2007; 116: Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, et al. The remote ischemic pre-conditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 2004; 19: Epub 2004 Aug Kristiansen SB, Henning O, Kharbanda RK, Nielsen-Kudsk JE, Schmidt MR, Redington AN, et al. Remote pre-conditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism. Am J Physiol Heart Circ Physiol 2005; 288:H Epub 2004 Oct Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, Kharbanda RK, et al. Remote ischemic pre-conditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a KATP channel-dependent mechanism. Transplantation 2005; 79: Hausenloy DJ, Yellon DM. The evolving story of conditioning to protect against acute myocardial ischemia reperfusion injury. Heart 2007; 93: Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic pre-conditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006; 47: Epub 2006 May Bhatt DL, Topol EJ. Does creatinine kinase-mb elevation after percutaneous coronary intervention predict outcomes in 2005? periprocedural enzyme elevation predicts adverse outcome. Circulation 2005; 112: Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000; 190: Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia: reperfusion injury. Cardiovasc Res 1999; 43: Walsh SR, Tang TY, Sadat U, Gaunt ME. Remote ischemic preconditioning in major vascular surgery. J Vasc Surg 2009; 49: Epub 2008 Oct Shmidt MR, Smerup M, Koustautinov IE, Shimizu M, Li J, Cheung M, et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic pre-conditioning. Am J Physiol Heart Circ Physiol 2007; 99: Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeanbility transition pore opening at reperfusion protects against ischemia: reperfusion injury. Cardiovasc Res 2003; 60: Bernardo NL, D'Angelo M, Okubo S, Joy A, Kukreja RC. Delayed ischemic pre-conditioning is mediated by opening of ATP: sensitive potassium channels in the rabbit heart. Am J Physiol 1997; 267:H Wang L, Oka N, Tropak M, Callnan J, Lee J, Wilson G. Remote ischemic pre-conditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest. J Thorac Cardiovasc Surg 2008; 136: Gho BC, Schoemaker RG, Van den Doel MA, Dunckar DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: Comment in: Circulation 1997; 96: Dickson EW, Reinhardt CP, Renzi FP, Becker RC, Porcaro WA, Heard SO. Ischemic pre-conditioning may be transforable via whole blood transfusion: preliminary evidence. J Thromb Thrombolysis 1999; 8: Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (7):
V Venugopal, 1 D J Hausenloy, 1 A Ludman, 1 C Di Salvo, 2 S Kolvekar, 2 J Yap, 2 D Lawrence, 2 J Bognolo, 2 D M Yellon 1. Cardiovascular surgery
See Editorial, p 1553 1 The Hatter Cardiovascular Institute, University College London Hospital, London, UK; 2 The Heart Hospital, University College London Hospitals NHS Trust, London, UK Correspondence
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationcardiac pre and post conditioning
cardiac pre and post conditioning i Stefan De Hert Department of Anesthesiology University Hospital Ghent University of Ghent 2010 Universitair Ziekenhuis Gent Belgium = limited exposition to a small potential
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationImproving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark
Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The
More informationBasic Mechanisms of Remote Ischemic Conditioning
Basic Mechanisms of Remote Ischemic Conditioning Rajesh K Kharbanda Oxford, GB ESC 2012. From Bench to Practice: Bridging the gap Mechanisms and Clinical use of Ischaemic Conditioning Disclosure Shareholder
More informationSean Davidson. The Hatter Cardiovascular Institute University College London, UK
Key pathways to ischemia-reperfusion injury Sean Davidson The Hatter Cardiovascular Institute University College London, UK Outline What is ischaemia-reperfusion injury? What causes ischaemia-reperfusion
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationIschemia-reperfusion injury (IRI) complicates myocardial
Arrhythmia/Electrophysiology K ATP Channel Activation Induces Ischemic Preconditioning of the Endothelium in Humans In Vivo M.W. Broadhead, MRCP, FRCA; R.K. Kharbanda, PhD, MRCP; M.J. Peters, PhD, MRCP;
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationIN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION
IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION Michel Carrier, MD L. Conrad Pelletier, MD Raymond Martineau, MD Michel Pellerin, MD
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationRationale for Left Ventricular Support During Percutaneous Coronary Intervention
Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Associate Professor, Division of Cardiology Director, Acute Circulatory Support Program
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationPathophysiology of ischemia-reperfusion injury (and how to protect against it )
Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Dr Derek J Hausenloy Reader in Cardiovascular Medicine BHF Senior Clinical Research Fellow Honorary Consultant Cardiologist
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationEffect of Remote Ischemic Preconditioning on the Periprocedural Myocardial Injury Events during Elective Percutaneous Coronary Intervention
Hiroshima J. Med. Sci. Vol. 67, Special Issue, May, 2018 8 Effect of Remote Ischemic Preconditioning on the Periprocedural Myocardial Injury Events during Elective Percutaneous Coronary Intervention N
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationAcute heart failure: ECMO Cardiology & Vascular Medicine 2012
Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationAntonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017
Parigi: May 16-19, 2017 Miracor Symposium Speaker: 15 Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy Nothing to disclose PiCSO Impulse System Elective high risk
More informationAlfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE
Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE Management in CHD Medical (medikamentosa) Intervensi 1. Percutaneous ( PTCA & stenting ) 2. Surgical ( CABG, CABG & mitral
More informationECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More informationManagement of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist
Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic
More informationShould We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary Disease?
Australian Journal of Basic and Applied Sciences, 3(1): 49-54, 2009 ISSN 1991-8178 Should We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationHigh Risk PCI for Heart Failure
High Risk PCI for Heart Failure Ray Matthews MD Professor of Clinical Medicine Chief, Division of Cardiovascular Medicine University of Southern California Los Angeles, California Disclosures Abiomed Research
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationReview Article Clinical Applications of Remote Ischemic Preconditioning
Cardiology Research and Practice Volume 2012, Article ID 620681, 9 pages doi:10.1155/2012/620681 Review Article Clinical Applications of Remote Ischemic Preconditioning Kristin Veighey 1 and Raymond J.
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationHOW TO PREPARE A GOOD ACCEPTED
HOW TO PREPARE A GOOD ABSTRACT AND GET IT ACCEPTED This is an interactive session; be free to interrupt and ask questions at any time during the talk! Some useful points when deciding if and where to submit
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationExtra Corporeal Life Support for Acute Heart failure
Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical
More informationSteph ani eph ani Mi M ck i MD Cleveland Clinic
Stephanie Mick MD Stephanie Mick MD Cleveland Clinic Upper hemisternotomy AVR Ascending Aorta MVr Thoracotomy Based Anterior AVR Lateral Thoracotomy Mitral/Tricuspid surgery Robotically assisted surgery
More informationCirculatory Support: From IABP to LVAD
Circulatory Support: From IABP to LVAD Howard A Cohen, MD, FACC, FSCAI Director Division of Cardiovascular Intervention Co Director Cardiovascular Interventional ti Laboratories Lenox Hill Heart & Vascular
More informationRemote ischemic conditioning in the STEMI and stroke: are we ready for clinical implementation?
Remote ischemic conditioning in the STEMI and stroke: are we ready for clinical implementation? Hans Erik Bøtker, MD, Ph.D. Aarhus University Hospital Skejby Denmark ACC Rockies 2013 17. March 2013 Presenter
More informationShould We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease?
1 Should We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease? 1 Nasr Hegazy, Khaled Fawzy, 2 Mostafa El-Hamamsy, 3 Abdelsalam Elhenawy
More informationCoronary artery bypass grafting (CABG) without an
Coronary Artery Bypass Grafting on the Beating Heart Evaluated With Integrated Backscatter Kenichi Imasaka, MD, Shigeki Morita, MD, Ichiro Nagano, MD, Munetaka Masuda, MD, Ryuji Tominaga, MD, and Hisataka
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationWarm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery
Nardi et al. Cell Death Discovery DOI 10.1038/s41420-018-0031-z Cell Death Discovery ARTICLE Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationRay Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California
High Risk PCI Making Possible the Impossible Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California Disclosures Abiomed Research Support Consulting Agreement
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Percutaneous Coronary Intervention https://www.youtube.com/watch?v=bssqnhylvma Types of PCI Procedures Balloon Angioplasty Rotational Atherectomy Coronary Stent Balloon Inflation Rotational Atherectomy
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationRecovering Hearts. Saving Lives.
Recovering Hearts. Saving Lives ṬM The Door to Unload (DTU) STEMI Safety & Feasibility Pilot Trial November 218 Recovering Hearts. Saving Lives. LEGAL DISCLAIMERS This presentation includes select slides
More informationNational Vascular Registry
National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationCORONARY ARTERY BYPASS GRAFT
CORONARY ARTERY BYPASS GRAFT Coronary artery disease develops because of hardening of the arteries (arteriosclerosis) that supply blood to the heart muscle. In the diagnosis of coronary artery disease,
More informationStroke Net Grand Round Webinar
Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationSupplementary Online Content
Supplementary Online Content Zarbock A, Schmidt C, Van Aken H, et al; for the RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationCardiovascular Concerns in Intermediate Care
Cardiovascular Concerns in Intermediate Care GINA ST. JEAN RN, MSN, CCRN-CSC CLINICAL NURSE EDUCATOR HEART AND & CRITICAL AND INTERMEDIATE CARE Objectives: Identify how to do a thorough assessment of the
More informationReoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes
Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationFFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium
FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationMinimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques
Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques Konstadinos A Plestis, MD System Chief of Cardiothoracic and Vascular
More informationORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery
ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationGoing on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia
Going on Bypass What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia Circulation Brain Liver Kidneys Viscera Muscle Skin IVC, SVC Pump Lungs R.A. L.V.
More informationNstemi But Stemi-De Winters Sign
Cardiology and Angiology: An International Journal 3(3): 162-166, 2015, Article no.ca.2015.015 ISSN: 2347-520X SCIENCEDOMAIN international www.sciencedomain.org Nstemi But Stemi-De Winters Sign Prem Krishna
More informationSupplementary Material to Mayer et al. A comparative cohort study on personalised
Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationFrom Recovery to Transplant: One Patient's Journey
From Recovery to Transplant: One Patient's Journey Tonya Elliott, RN, MSN Assist Device and Thoracic Transplant Coordinator Inova Transplant Center at Inova Fairfax Hospital Falls Church, VA Introduction
More informationPERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW
PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research
More informationClinical Policy Bulletin: Remote Ischemic Conditioning
Remote Ischemic Conditioning Page 1 of 15 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Remote Ischemic Conditioning Revised April
More information12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2
Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial
More informationA case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD
A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD NAVAL HOSPITAL OF ATHENS case presentation Female, 81yo Hx: diabetes mellitus, hypertension, chronic anaemia presented
More informationIschemic heart disease carries an increased risk of malignant
Ischemic Preconditioning Suppresses Ventricular Tachyarrhythmias After Myocardial Revascularization Zhong-Kai Wu, MD; Tiina Iivainen, MD; Erkki Pehkonen, MD; Jari Laurikka, MD; Matti R. Tarkka, MD Background
More informationNational Vascular Registry
National Vascular Registry Angioplasty Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationResults of Ischemic Heart Disease
Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to
More information